The inquiry represents a search for local medical practitioners offering a specific onabotulinumtoxinA treatment protocol. This protocol is indicated for the prophylactic treatment of chronic migraine in adults. The user is seeking a convenient location to access this therapeutic intervention.
Accessing this treatment can significantly reduce the frequency and severity of migraine headaches, improving quality of life. The FDA approved onabotulinumtoxinA for chronic migraine in 2010, establishing it as a recognized and accepted therapy for individuals who experience 15 or more headache days per month, each lasting four hours or more.